BCL2 and neoplasm: All these results suggest that SOCS3 is a direct target of miR-222-3p, and exosomic miR-222-3p might enhance tumor malignancy through SOCS3 and its downstream effectors, such as the Jak2/Stat3 and Bcl-2 pathways.